Effects of chromium picolinate on vascular reactivity and cardiac ischemia-reperfusion injury in spontaneously hypertensive rats

Pharmacological Reports

Volumn 62, Issue 4, 2010, Pages 674-682

  Abebe, Worku ^a   Liu, Jun Yao ^a   Wimborne, Hereward ^a   Mozaffari, Mahmood S ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Chromium picolinate; Heart; Ischemia reperfusion injury; Spontaneously hypertensive rat; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; CHROMIUM PICOLINATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIET SUPPLEMENTATION; DRUG MECHANISM; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; HYPERTENSION; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE RELAXATION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 77957976572     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70324-8     Document Type: Article

References (30)

1. Abebe W: Effects of taurine on the reactivity of aortas from diabetic rats. Life Sci, 2008, 82, 279-289.
2. Abebe W, Hussain T, Olanrewaju H, Mustafa SJ: Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery. Am J Physiol, 1995, 269, H1672-678.
3. Abebe W, Mozaffari MS: Effects of chronic taurine treatment on reactivity of the rat aorta. Amino Acids, 2000, 19, 615-623.
4. Abebe W, Mozaffari MS: Vascular reactivity changes in glucose-intolerant rat. J Cardiovasc Pharmacol, 2007, 50, 590-597.
5. Anderson RA: Chromium in the prevention and control of diabetes. Diabetes Metab, 2000, 26, 22-27.
6. Anderson RA, Bryden NA, Polansky MM: Lack of toxicity of chromium chloride and chromium picolinate in rats. J Am Coll Nutr,1997, 16, 273-279.
7. Anton SD, Morrison CD, Cefalu WT, Martin CK, Coulon S, Geiselman P, Han H et al.: Effects of chromium picolinate on food intake and satiety. Diabetes Technol Ther, 2008, 10, 405-412.
8. Cefalu WT, Hu FB: Role of chromium in human health and in diabetes. Diabetes Care, 2004, 27, 2741-2751.
9. Chen K, Pittman RN, Popel AS: Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal, 2008, 10, 1185-1198.
10. Cohen JD: Overview of physiology, vascular biology, and mechanisms of hypertension. J Manag Care Pharm, 2007, 13, S6-8.
11. Cooper ME, Bonnet F, Oldfield M, Jandeleit-Dahm K: Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens, 2001, 14, 475-486.
12. Davies S, McLaren Howard J, Hunnisett A, Howard M: Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients - implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism, 1997, 46, 469-473.
13. Di Lisa F, Bernardi P: Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition. Cardiovasc Res, 2005, 66, 222-232.
14. 3 improves obesity-induced cardiac contractile defect in ob/ob mice. Obesity, 2007, 15, 2699-2711.
15. Hepburn DD, Vincent JB: In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement. Chem Res Toxicol, 2002, 15, 93-100.
16. Javadov S, Karmazyn M, Escobales N: Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther, 2009, 330, 670-678.
17. Kopilas MA, Dang LN, Anderson HD: Effect of dietary chromium on resistance artery function and nitric oxide signaling in the sucrose-fed spontaneously hypertensive rat. J Vasc Res. 2007, 44, 110-118.
18. Lamson DW, Plaza SM: The safety and efficacy of high-dose chromium. Altern Med Rev, 2002, 7, 218-235.
19. Moore JW, Maher MA, Banz WJ, Zemel MB: Chromium picolinate modulates rat vascular smooth muscle cell intracellular calcium metabolism. J Nutr, 1998, 128, 180-184.
20. Mozaffari MS, Patel C, Ballas C, Schaffer SW: Effects of chronic chromium picolinate treatment in uninephrectomized rat. Metabolism, 2005, 54, 1243-1249.
21. 2+ channel. Hypertension, 2006, 47, 912-919.
22. ATP channels and GSK-3β: Interaction with the MPT pore. Am J Hypertens, 2008, 21, 570-575.
23. Oparil S, Chen YF, Peng N, Wyss JM: Anterior hypothalamic norepinephrine, atrial natriuretic peptide, and hypertension. Front Neuroendocrinol, 1996, 17, 212-246.
24. Penumathsa SV, Thirunavukkarasu M, Samuel SM, Zhan L, Maulik G, Bagchi M, Bagchi D, Maulik N: Niacin-bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury. Biochim Biophys Acta, 2009, 1792, 39-48.
25. Preuss HG, Grojec PL, Lieberman S, Anderson RA: Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol, 1997, 47, 325-330.
26. Preuss HG, Jarrell ST, Scheckenbach R, Lieberman S, Anderson RA: Comparative effects of chromium, vanadium and gymnema sylvestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr, 1998, 17, 116-123.
27. Proctor SD, Kelly SE, Stanhope KL, Havel PJ, Russell JC: Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR: LA-cp rat. Diabetes Obes Metab, 2007, 9, 87-95.
28. Simonsen U, Rodriguez-Rodriguez R, Dalsgaard T, Buus NH, Stankevicius E: Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation. Pharmacol Rep, 2009, 61, 105-115.
29. Subramanian R, MacLeod KM: Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats. Eur J Pharmacol, 2003, 477, 143-152.
30. Thirunavukkarasu M, Penumathsa SV, Juhasz B, Zhan L, Cordis G, Altaf E, Bagchi M et al.: Niacin-bound chromium enhances myocardial protection from ischemiareperfusion injury. Am J Physiol, 2006, 291, H820-H826.